Fischer Ratio Calculator
Fischer Ratio Calculator
Calculate the Fischer ratio of branched-chain to aromatic amino acids, used to assess hepatic encephalopathy risk and nutritional status in liver failure.
Fischer Ratio
BCAA ÷ AAALeucine 95, isoleucine 52, valine 180, phenylalanine 78, tyrosine 92 µmol/L
Formula
- BCAA
- branched-chain amino acids — leucine, isoleucine, valine — metabolised mainly in skeletal muscle
- AAA
- aromatic amino acids — phenylalanine, tyrosine — cleared by the liver
- normal ratio
- approximately 3 to 4 in health, falling as liver failure progresses
Worked example
Leucine 95, isoleucine 52, valine 180, phenylalanine 78, tyrosine 92 µmol/L
BCAA = 95 + 52 + 180 = 327 µmol/L
AAA = 78 + 92 = 170 µmol/L
327 ÷ 170 = 1.92 → reduced
Interpreting the ratio
| Fischer ratio | Pattern | Consider |
|---|---|---|
| < 1.8 | Markedly reduced | Advanced hepatic decompensation; encephalopathy risk |
| 1.8 – 2.5 | Reduced | Established liver failure; nutritional assessment |
| > 2.5 | Normal range | No amino acid evidence of decompensation |
What the ratio reflects, and its limits
The Fischer ratio compares the branched-chain amino acids — leucine, isoleucine and valine — against the aromatic amino acids phenylalanine and tyrosine. It is normally around 3 to 4, and falls progressively as liver failure advances, making it both a marker of hepatic decompensation and, historically, a treatment target.
The mechanism is worth explaining. Branched-chain amino acids are metabolised mainly in skeletal muscle rather than the liver, and are consumed as an alternative energy source in the catabolic state that accompanies liver failure, so their level falls. Aromatic amino acids, by contrast, are normally cleared by the liver and accumulate as hepatic clearance fails — the two changes move the ratio in the same direction.
The false-neurotransmitter hypothesis proposes that the resulting flood of aromatic amino acids across the blood-brain barrier displaces normal neurotransmitter synthesis and contributes to hepatic encephalopathy, by favouring production of false neurotransmitters over dopamine and noradrenaline. This provided the rationale for branched-chain amino acid supplementation as a treatment.
Be candid about the evidence. BCAA supplementation reliably improves the ratio and there is moderate-quality evidence it improves encephalopathy, but the effect on survival is not established, and current guidelines give it a supportive rather than central role. In practice the ratio itself is now used more in research and nutritional assessment than in routine clinical decision-making, having been largely superseded by direct clinical grading for managing encephalopathy day to day.
Frequently asked questions
What is a normal Fischer ratio?
Roughly 3 to 4 in a healthy adult. It falls progressively as liver failure advances, reflecting both reduced branched-chain and increased aromatic amino acid levels.
Why does the ratio fall in liver failure?
Branched-chain amino acids are consumed by muscle as an energy source during the catabolic state of liver failure, while aromatic amino acids, normally cleared by the liver, accumulate as clearance fails.
Does correcting the ratio with BCAA supplementation help?
It reliably improves the ratio and there is moderate evidence it improves encephalopathy, but an effect on survival has not been established. It is used adjunctively rather than as primary treatment.
Is the Fischer ratio still used clinically?
Less than it once was. It has been largely superseded by direct clinical grading of encephalopathy and is now used more in nutritional assessment and research.
Related calculators
References
- Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet. 1971;2(7715):75–80.
- Gluud LL, Dam G, Les I, et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;5:CD001939.
Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.